European Medical Journal Oncology
European Medical Journal
Journal websitePeer review: Double-blind review
Evaluation status available after sign-in
About the journal
European Medical Journal Oncology is an open-access journal published by European Medical Journal in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 22 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- European Medical Journal
- ISSN
- 2054-619X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 66
- Declared review time
- 22 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2015-12-29
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 22 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
66
Most recent article
2 years ago
Average review time (journal-declared via DOAJ)
22weeks
Works in OpenAlex
193
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
5
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy9
- Last DOAJ review date
- 2025-06-11
- Added to DOAJ
- 2015-12-29
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 74%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- OncologyEMJ.
- Source type
- journal
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Lung Cancer Treatments and Mutations
- BRCA gene mutations in cancer
Show all subjects (75)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Endometrial and Cervical Cancer Treatments
- Advanced Breast Cancer Therapies
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Lung Cancer Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Endometrial and Cervical Cancer Treatments
- Endometrial and Cervical Cancer Treatments
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Advances in Oncology and Radiotherapy
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- BRCA gene mutations in cancer
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Gastric Cancer Management and Outcomes
- BRCA gene mutations in cancer
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- HER2/EGFR in Cancer Research
- Prostate Cancer Treatment and Research
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Science, Research, and Medicine
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
- Pancreatic and Hepatic Oncology Research
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
- Lymphoma Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Urinary and Genital Oncology Studies
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Urinary and Genital Oncology Studies
- Bladder and Urothelial Cancer Treatments
- Gastrointestinal Tumor Research and Treatment
- CAR-T cell therapy research
- Bladder and Urothelial Cancer Treatments
- Gastrointestinal Tumor Research and Treatment
Keywords (DOAJ)
- oncology
- medical oncology
- radiation oncology
- surgical oncology
- paediatric oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ